Obstructive sleep apnea

What research says

Prevalence. Depending on severity threshold and population, estimates range from about 10 to 30 percent of adults meeting some OSA criteria. Substantial gender difference (higher in men) that narrows with menopause. Most cases remain undiagnosed.

Course. Chronic condition. Often worsens gradually with age and weight gain. Improves with weight loss and treatment.

Comorbidity and consequences. - Cardiovascular disease (hypertension, coronary artery disease, atrial fibrillation, heart failure) - Stroke - Type 2 diabetes and insulin resistance - Depression and anxiety - Cognitive impairment and elevated risk of dementia - Motor vehicle accidents - Workplace accidents - Mortality

Treatment evidence. - CPAP: strong evidence for reducing sleepiness, improving cardiovascular outcomes, improving mood and cognition, reducing accident risk. Adherence is the main limitation; roughly 50-70 percent of prescribed patients achieve adequate adherence. - Mandibular advancement devices: evidence for mild-to-moderate OSA and some moderate-to-severe cases. - Weight loss: substantial benefit; bariatric surgery in appropriate candidates can produce major OSA improvement or resolution. - Positional therapy: for patients with primarily supine OSA. - Hypoglossal nerve stimulation (Inspire): FDA-approved 2014 for select patients with moderate-to-severe OSA who cannot tolerate CPAP. - Upper airway surgery: mixed evidence, patient selection dependent.

Effect of CPAP on mental health outcomes. RCTs and cohort studies demonstrate improvements in depression scores, anxiety scores, and cognitive function with consistent CPAP use in patients with OSA and mental health conditions.

What OSA is

Under the International Classification of Sleep Disorders, Third Edition (ICSD-3), OSA is diagnosed when a person has:

• 5 or more predominantly obstructive respiratory events (apneas, hypopneas, or respiratory effort-related arousals) per hour of sleep on polysomnography, plus symptoms or medical comorbidities, OR
• 15 or more events per hour of sleep, regardless of symptoms

Severity classification: - Mild: 5-14 events per hour (apnea-hypopnea index, AHI, 5-14) - Moderate: 15-29 events per hour - Severe: 30 or more events per hour

Types of respiratory events: - Apnea: complete or near-complete cessation of airflow for 10 seconds or more - Hypopnea: reduction in airflow of 30 to 90 percent with an associated oxygen desaturation or arousal - Respiratory effort-related arousal (RERA): arousal from sleep triggered by increased respiratory effort without meeting apnea or hypopnea criteria

OSA is distinct from central sleep apnea, in which the breathing effort itself is reduced (usually due to a central nervous system driver) rather than the airway being obstructed. Some patients have both (mixed apnea).

What it feels like

The classic OSA presentation:

During sleep: - Loud, chronic snoring - Witnessed pauses in breathing followed by gasping or choking - Restless sleep with frequent brief awakenings the person may not remember - Frequent urination overnight (nocturia)

During the day: - Non-restorative sleep despite adequate time in bed - Excessive daytime sleepiness - Morning headaches - Difficulty concentrating - Memory problems - Irritability - Depressed mood - Reduced motivation and energy - Dozing off at inappropriate times (driving, meetings, meals)

Many patients don't experience all of these; some primarily notice sleepiness, others primarily notice the cognitive or mood effects. Some patients don't feel particularly sleepy but still have substantial cognitive or metabolic effects.

In women: presentation is often subtler. Women with OSA more commonly present with fatigue, insomnia, mood symptoms, and morning headaches rather than the classic snoring and daytime sleepiness. This is one reason OSA is underdiagnosed in women.

In older adults: similarly subtle presentation. Fatigue and cognitive slowing may be attributed to aging.

Why OSA matters for mental health

The connection between OSA and mental health conditions is bidirectional and substantial.

Depression. Substantial overlap. Meta-analyses find depression rates in OSA patients are 2-3 times higher than in the general population, and OSA rates in depression are elevated. Some patients treated for depression have partial or no response until OSA is identified and treated. CPAP has evidence for improving depressive symptoms in patients with both conditions.

Anxiety. Elevated rates of anxiety in OSA populations. Fragmented sleep is anxiogenic. CPAP often improves anxiety.

PTSD. OSA is particularly common in PTSD populations. Combat veterans have very high rates. The physical stress response, weight changes, and sleep disruption of PTSD all contribute. CPAP improves both PTSD symptoms and sleep quality.

Cognitive impairment. Attention, working memory, executive function, and processing speed are all impaired in untreated OSA. Substantial reversal with CPAP, though some cognitive effects may persist particularly with severe long-standing untreated disease.

ADHD. Some ADHD-like presentations are actually driven by OSA. Not every attention problem is ADHD; sleep evaluation is often useful. Some patients with true ADHD have concomitant OSA that also needs treatment.

Fatigue as depression. Many patients present to primary care with fatigue that gets attributed to depression when OSA is the actual driver. Screening for OSA in fatigue and depression presentations is often high-yield.

Antidepressant partial response. Persistent fatigue, cognitive fog, and depressed mood in a patient on an SSRI who has responded partially warrants OSA screening.

Alcohol and sedatives worsen OSA. Substance use contexts affect OSA management. Cannabis, particularly high-doses, may worsen OSA in some patients.

Differential diagnosis and comorbidities

Central sleep apnea. Reduced respiratory drive rather than airway obstruction. Different mechanism, different treatment (typically adaptive servo-ventilation or other approaches). May coexist with OSA.

Upper airway resistance syndrome. RERAs without meeting full apnea/hypopnea criteria. Similar consequences and often treated similarly.

Insomnia disorder. Different mechanism. Some patients have both.

Narcolepsy. Sudden sleep attacks, cataplexy in Type 1. Often distinguishable but can coexist.

Restless legs syndrome and periodic limb movement disorder. Common comorbidity.

Depression with sleep symptoms. Depression can produce fatigue and non-restorative sleep. May coexist with OSA. Sleep study appropriate when suspicion is high.

Hypothyroidism. Can produce fatigue overlapping with OSA presentation. Should be screened.

Chronic fatigue syndrome / ME/CFS. Different mechanism but presenting fatigue can overlap.

Idiopathic hypersomnia. Excessive sleep and sleepiness without OSA. Distinguishable by sleep study.

Circadian rhythm disorders. Sleep timing problems rather than sleep breathing problems.

Why it happens

Anatomical factors: - Excess soft tissue in the airway (obesity contributes, but not the only factor) - Long soft palate, large tongue, large tonsils/adenoids - Retrognathia (recessed lower jaw) - Narrow airway - Nasal obstruction

Physiological factors: - Muscle tone loss during sleep (particularly REM sleep) - Age-related muscle tone changes - Certain medications (sedatives, opioids, alcohol) that reduce upper airway tone

Risk factors: - Male sex (until menopause; then women catch up) - Obesity (strong risk factor) - Aging - Family history - Certain craniofacial features - Endocrine conditions (hypothyroidism, acromegaly, PCOS) - Neuromuscular disorders

Contributors that worsen existing OSA: - Alcohol before bedtime - Sedating medications (benzodiazepines, opioids, some sleep aids) - Weight gain - Sleeping supine (in positional OSA) - Nasal congestion

Assessment

Screening tools: - STOP-BANG questionnaire (Snoring, Tiredness, Observed apnea, high blood Pressure, BMI, Age, Neck circumference, Gender male) - Epworth Sleepiness Scale for daytime sleepiness - Berlin Questionnaire

Positive screening warrants sleep study.

Sleep study options: - Home sleep apnea test (HSAT): appropriate for high pretest probability, uncomplicated cases. Limited monitoring but adequate for OSA diagnosis in most cases. - In-lab polysomnography (PSG): comprehensive monitoring. Preferred when other sleep disorders are suspected, when HSAT is technically inadequate, or when comorbid medical conditions require more detailed assessment.

Post-diagnosis assessment: - Severity classification - Presence of comorbidities - Assessment for optimal treatment - Baseline symptoms (mood, cognition, sleepiness) for treatment response tracking

Treatment

CPAP (continuous positive airway pressure) is first-line and remains the gold standard for moderate-to-severe OSA.

• Provides continuous air pressure through a mask that keeps the airway open
• Auto-titrating CPAP (APAP) adjusts pressure dynamically
• Bi-level (BiPAP) provides different pressures for inspiration and expiration; useful for higher pressures or specific indications
• Modern devices are quieter and smaller than older generations
• Various mask options: nasal pillows, nasal masks, full-face masks; individual fitting matters

Adherence. The main challenge. Approximately 50-70 percent of prescribed patients use CPAP adequately (typically defined as 4+ hours per night, 5+ nights per week). Strategies that improve adherence: - Adequate mask fitting and comfort optimization - Ramp features that gradually increase pressure - Heated humidification - CBT for insomnia adaptations for CPAP - Support during the initial adjustment period - Follow-up and adjustment

When CPAP doesn't work or isn't tolerated:

• Mandibular advancement device (MAD, oral appliance): dental device that repositions the lower jaw forward. Effective for mild-to-moderate OSA and some moderate-to-severe cases. Custom-fitted by a dentist trained in dental sleep medicine.
• Positional therapy: for patients with primarily supine OSA. Devices or techniques that discourage supine sleeping.
• Weight loss: substantial benefit when applicable. Bariatric surgery in appropriate candidates.
• Hypoglossal nerve stimulation (Inspire): implanted device that stimulates the hypoglossal nerve during breathing to maintain airway patency. FDA-approved 2014. Select patients (BMI under 32-40 depending on device, moderate-to-severe OSA, CPAP failure).
• Surgery: uvulopalatopharyngoplasty (UPPP), tonsillectomy, maxillomandibular advancement, others. Mixed evidence, careful patient selection.
• Pharmacological approaches: emerging area. Some medications targeting upper airway muscle tone are in trials.

Positive treatment of any co-occurring conditions: - Depression: standard treatment; CPAP as adjunct - Cardiovascular disease: standard management - Diabetes: standard management - Weight: sustained weight loss when possible

Behavioral considerations: - Reducing alcohol, particularly before bedtime - Reviewing sedating medications - Nasal management for chronic congestion - Sleep position (side sleeping) if positional

Cultural and structural considerations

Access to sleep studies and treatment varies substantially. Home sleep testing has increased access but interpretation and follow-up remain important.

CPAP adherence requires ongoing support that varies in availability. Follow-up appointments, mask refitting, and adjustment help.

Insurance coverage for CPAP typically requires demonstrated adherence, which creates a barrier for patients struggling with adjustment.

Racial disparities in OSA diagnosis and treatment exist. Black Americans are more likely to have severe OSA at diagnosis, reflecting delays in identification.

Occupation matters. Commercial drivers, pilots, and other safety-sensitive positions require OSA screening and adequate treatment.

Living with OSA

For the person. Consistent CPAP use is the single most important factor in treatment success. Give initial adjustment time (2-6 weeks); early frustration is common and often resolves. Weight management when applicable. Following up with the sleep team when things aren't working matters more than giving up. Untreated OSA has real health consequences; treated OSA is compatible with a full life.

For family or partners. Recognizing loud snoring and witnessed apneas is often the alert that brings someone to evaluation. Bed partners' feedback matters. Supporting CPAP use during the adjustment period helps. Some bed partners find CPAP itself disruptive; modern devices are quieter than older generations.